Related Experiment Video
Updated: Apr 23, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without
Marcelo Corti1, Maria Priarone1, Ricardo Negroni2
1School of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Introduction:
Cryptococcosis is an opportunistic mycosis, especially in patients that are human immunodeficiency virus (HIV)-positive, and frequently involves the central nervous system.
Methods:
We assessed the potential of ventriculoperitoneal shunting (VPS) in preventing mortality due to uncontrollable intracranial hypertension (ICH) in 15 patients with acquired immunodeficiency syndrome (AIDS)-related cryptococcal meningitis.
Results:
After 2 weeks of antifungal therapy consisting of amphotericin B deoxycholate with or without fluconazole, patients with persistent ICH underwent VPS, despite having persistent Cryptococcus neoformans infection. In 12 patients, the uncontrollable ICH was resolved by VPS.
Conclusions:
Patients with cryptococcal meningoencephalitis who have ICH must be considered for VPS even with positive cerebrospinal fluid cultures.
Insights
Ventriculoperitoneal shunting (VPS) can prevent mortality in patients with acquired immunodeficiency syndrome (AIDS)-related cryptococcal meningitis and intracranial hypertension (ICH). This procedure is effective even when Cryptococcus neoformans infection persists after antifungal therapy.
Area of Science:
- Infectious Diseases
- Neurosurgery
- Critical Care Medicine
Background:
- Cryptococcosis is a significant opportunistic mycosis, particularly in human immunodeficiency virus (HIV)-positive individuals.
- Central nervous system involvement, specifically cryptococcal meningitis, is a common and serious complication.
Purpose of the Study:
- To evaluate the efficacy of ventriculoperitoneal shunting (VPS) in managing uncontrollable intracranial hypertension (ICH) in patients with acquired immunodeficiency syndrome (AIDS)-related cryptococcal meningitis.
- To assess the impact of VPS on preventing mortality in this patient population.
Main Methods:
- A cohort of 15 patients with AIDS-related cryptococcal meningitis and persistent ICH was studied.
- Ventriculoperitoneal shunting (VPS) was performed after 2 weeks of antifungal therapy (amphotericin B deoxycholate with or without fluconazole) if ICH remained uncontrollable.
- Patients had persistent Cryptococcus neoformans infection at the time of VPS.
Main Results:
- Ventriculoperitoneal shunting (VPS) successfully resolved uncontrollable intracranial hypertension (ICH) in 12 out of 15 patients.
- The procedure demonstrated a potential benefit in managing a critical complication of cryptococcal meningitis in AIDS patients.
Conclusions:
- Ventriculoperitoneal shunting (VPS) should be considered for patients with cryptococcal meningoencephalitis experiencing intracranial hypertension (ICH), even in the presence of positive cerebrospinal fluid cultures.
- VPS offers a viable option for managing refractory ICH in this immunocompromised population.
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Brain Abscess l: Introduction
Cerebral Edema ll: Pathophysiology
Viral Meningitis
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

